Status:

UNKNOWN

Sentinel Node Detection in Endometrial Cancer: A Consolidation Study on Detection Rates of Metastatic Disease

Lead Sponsor:

Region Skane

Conditions:

Sentinel Lymph Node

Endometrial Cancer

Eligibility:

FEMALE

18-85 years

Phase:

NA

Brief Summary

Evaluation of removal of Sentinel lymph nodes only for detection of pelvic lymph node metastases in high risk and low risk endometrial cancer.

Detailed Description

Consecutive patients with- and low risk endometrial cancer will be approached for eligibility for inclusion in a study evaluating the detection rates of pelvic metastatic disease by detection and remo...

Eligibility Criteria

Inclusion

  • Women of age 18 years and older at the time of informed consent.
  • Women with a pathologically proven endometrial carcinoma of any histologic subtype or grade, clinically stage I-II planned for primary surgery
  • A uterine size allowing minimally invasive surgery
  • Women must be able to understand and sign an informed consent in Swedish language.
  • Absence of any exclusion criteria

Exclusion

  • Non consenting patients
  • Ongoing pregnancy
  • Inability to understand written and/or oral study information
  • WHO performance status or conditions contraindicating adjuvant oncological treatment (WHO III or more)
  • Previous lower limb lymphedema ( only for the lymphedema part of study)
  • Evidence of locally advanced disease or intraabdominal/distant metastases at preoperative CT, MRI or ultrasonography.
  • Surgical contraindication to a laparoscopic approach or lymphadenectomy at surgeons discretion.
  • Anesthesiologic contraindication to a laparoscopic approach at the anesthetist's discretion
  • Allergy to Iodine
  • Patients with a known liver disease
  • Patients with a bleeding disorder or mandatory antithrombotic treatment.

Key Trial Info

Start Date :

February 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2023

Estimated Enrollment :

362 Patients enrolled

Trial Details

Trial ID

NCT03838055

Start Date

February 1 2019

End Date

December 1 2023

Last Update

February 12 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Gynecology and Obstetrics

Lund, Sweden, 22185